Journal of Capital Medical University ›› 2022, Vol. 43 ›› Issue (6): 867-872.doi: 10.3969/j.issn.1006-7795.2022.06.008

• Nuclear Medicine and Molecular Imaging Assists Clinical Diagnosis and Treatment • Previous Articles     Next Articles

Application value of 18F-FDG PET/CT in differential diagnosis of choroidal melanoma and choroidal metastatic carcinoma

Luo Shiyu1, Li Mei1*, Luo Sha1, Wang Shuang1, Zhang Juan1, Li Meng1, Nan Xiao1, Xian Junfang2   

  1. 1. Department of Nuclear Medicine, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China;
    2. Department of Radiology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China
  • Received:2022-09-30 Online:2022-12-21 Published:2022-11-30
  • Contact: *E-mail:lee_mei_bj@sina.com

Abstract: Objective To analyze the imaging characteristics and metabolic parameters of fluoro-18-deoxyglucose(18F-FDG) positron emission tomography/computed tomography(PET/CT) in patients with choroidal melanoma and choroidal metastatic carcinoma, and to explore its clinical application value in the diagnosis and differentiation of the two diseases. Methods The patients that underwent 18F-FDG PET/CT examination in the Department of Nuclear Medicine, Beijing Tongren Hospital, Capital Medical University from May 2020 to March 2022 and finally diagnosed as choroidal melanoma or choroidal metastatic carcinoma were enrolled. The CT imaging features and 18F-FDG PET metabolic parameters of the two diseases were compared with each other, the latter including maximum standardized uptake value (SUVmax), peak standardized uptake value (SUVpeak), and total lesion glycolysis (TLG). Chi-square test, Fisher exact test, two independent samples t-test and rank sum test were used to compare the differences of the above mentioned between the two group. Spearman correlation analysis was used to evaluate the correlation between metabolic parameters and lesion size. Results A total of 76 patients were enrolled, including 58 cases of choroidal melanoma and 18 cases of choroidal metastatic carcinoma. There were no significant differences in gender, age, and affected side between the two groups (all P> 0.05). There were statistically significant differences in the location(χ2=9.263, P=0.041)and shape(χ2=21.735, P<0.001)of lesions between the two groups. The thickness of the choroidal melanoma group was significantly higher than that of the choroidal metastatic carcinoma group (t=2.539, P=0.013). There was no significant difference in the largest basal diameter between the two groups (P>0.05). The SUVmax of the choroidal melanoma group was lower than that of the choroidal metastatic carcinoma group (P<0.05). There was no significant difference in SUVpeak and TLG between the two groups (all P>0.05). In the choroidal melanoma group, SUVmax, SUVpeak, and TLG were positively correlated with the largest basal diameter (r=0.528, 0.613, 0.732, all P<0.001) and thickness (r=0.521, 0.605, 0.730, all P<0.001). In the choroidal metastatic carcinoma group, SUVpeak and TLG were positively correlated with the largest basal diameter (r=0.528, 0.661, P=0.024, 0.003) and thickness (r=0.591, 0.688, P=0.010, 0.002). However, there was no significant correlation between SUVmax and the largest basal diameter and thickness (all P>0.05). Conclusion 18F-FDG PET/CT imaging findings and metabolic parameter SUVmax have certain value in the differential diagnosis of choroidal melanoma and metastatic carcinoma.

Key words: choroidal melanoma, choroidal metastatic carcinoma, positron emission tomography/computed tomography (PET/CT), metabolic parameters, the differential diagnosis

CLC Number: